Planning Committee

Program Planning Committee Chair:
Bernie J. O’Brien PhD, Professor, Department of Clinical Epidemiology & Biostatistics, McMaster University, St. Joseph’s Hospital, Hamilton, Ontario, Canada

Issues Panel & Contributed Workshop Committee Co-Chairs:
Andrew Briggs Dphil, Professor, Health Economics Research Centre, University of Oxford, Institute of Health Sciences Headington, Oxford and
Mark Sculpher, MSc
, PhD, Professor, University of York, Centre for Health Economics, Heslington York

Contributed Research Review Committee Chair:
Adrian Levy PhD, Professor, Center for Health Evaluation and Outcome Sciences, St. Paul's Hospital, University of British Columbia Vancouver, Canada and
Rajesh Balkrishnan, Associate Professor of Management and Policy Sciences, University of Texas School of Public Health, Houston, TX, USA (Assistant Abstract Chairperson)

Short Course Committee Co-chairs:
Lorne Basskin PharmD, President, Trinka Publications, Cooper City, FL, USA and
J. Jaime Caro MD, Scientific Director, Caro Research, Concord, MA, USA

Contributed Workshop Review Committee:
Dong-Churl Suh MBA, PhD, Associate Professor, College of Pharmacy, Rutgers University, Piscataway, NJ, USA
Pennifer Erickson PhD, Co-founder, O.L.G.A., State College, PA, USA
Lynda Bryant-Comstock, Manager, Environment and Policy, GlaxoSmithKline, Research Triangle Park, NC, USA
Deborah Marshall PhD, Innovus Research Inc., Burlington, ON, Canada
Rajesh Balkrishnan PhD, MS, Associate Professor, University of Texas, School of Public Health, Houston, TX, USA

Contributed Research Review Committee
Thomas Abbott PhD, MBA, Senior Director, Pharmaceutical Economics Merck & Co. Inc., US
Jeonghoon Ahn PhD, Assistant Professor University of Southern California, US
Lieven Annemans PhD, MSc, Mman, Director, HEDM, Belgium
Adam Atherley PhD, Health Economist, Centers for Disease Control, US
Mohan Bala, PhD, Associate Director, Centocor Inc.,
***Rajesh Balkrishnan PhD, Associate Professor, University of Texas School of Public Health, US
Richard Barron MS, Manager, Health Economics, Allergan, Inc, US
Lorne Basskin PharmD, President, Trinka Publications, US
Ramon Bautista MD, MBA, Assistant Professor of Neurology, University of Florida HSC/Jacksonville, US
Stephen Beard, Health Economist/Modeller, RTI Health Solutions, UK
Timothy Bell, RTI Health Solutions, US
Rami Ben-Joseph PhD, RPh, VP Operations, Health Process Management, US
Gilles Berdeaux MD, Health Economics Manager Laboratoires Alcon France, France
Stephen J. Boccuzzi PhD, Executive Director, Merck & Company, Inc., US
Somali Misra Burgess PhD, PharMetrics, Inc., US
Joseph C. Cappelleri PhD, Senior Associate Director, Pfizer Inc, US
Jean Carter PhD, PharmD, Assistant Professor, University of Montana, US
Amit Chhabra MD, MPH, Research Associate, Harvard Clinical Research Institute, US
Steven Clause PharmD, Research Assistant Professor, Dept. of Pharmacy Practice, Albany College of Pharmacy, US
John Coombs PharmD, Outcomes Research Scientist, Pfizer, US
Bruce Crawford MA, MPH, Project Director, Mapi Values, US
Suellen Curkendall PhD, Principal, Healthcare Data Analysis, US
Shelby D. Reed PhD, RPh, Assistant Research Professor, Duke Clinical Research Institute, US
Linda Davies MS, Reader and Director of Health Economics, University of Manchester, UK
Mei-Sheng Duh, Vice President, Analysis Group/Economics, US
Thomas Einarson PhD, Associate Professor, Faculty of Pharmacy, University of Toronto, Canada
Jeffrey Ellis PharmD, MS, Outcomes Research Specialist, Cleveland Clinic Foundation, US
Lida Etemad MS, PharmD, Sr Research Analyst, Ingenix, US
Christopher Evans PhD, MPH, Senior Project Director, Mapi Values, US
Kevin Farmer PhD, Associate Professor, University of Oklahoma, US
Elisabeth Fenwick PhD, University of York, United Kingdom
Jack Fincham PhD, Dean, University of Kansas, US
Ellen Friedla PharmD, MPH, Clincal Director, Heritage Information Systems, US
Yves M. Gagnon MSc, President, Occam Research & Consulting Inc, Canada
Neil Goldfarb BA, ABD, Director of Research, Office of Health Policy, Thomas Jefferson University US
Mugdha Gore PhD, BPharm, Principal Consultant, Avalon Health Solutions, Inc., US
Dennis Grauer PhD, RPh, MS, Assistant Professor, The University of Kansas, US
J. Pierre Gregoire PhD, Director, Health Economics & Outcomes Research, Merck Frosst Canada & Co., Canada
Jens Grueger PhD, Head of Health Economics Department, Novartis Pharmaceuticals AG, Switzerland
Cheryl Hankin PhD, Associate Director, Outcomes Research, McNeil Consumer and Specialty Pharmaceuticals, US
A.Brett Hauber PhD, Senior Economist, RTI Health Solutions, US
Daniel Huse MA, Director, MarketScan Studies, Medstat, US
Uchenna Iloeje MD, MPH, FACP, Associate Director – Outcomes, Bristol-Myers Squibb, US
Michael Iskedjian RPh, MSc, President, PharmIdeas Research & Consulting Inc., Canada
Joseph Jackson PhD, Group Director, Health Economic Policy and External Relations, Bristol-Myers Squibb, US
Ravishankar Jayadevappa PhD, Research Assistant Professor, University of Pennsylvania, US
Sachin Kamal-Bahl Bpharm, MS, University of Maryland, Baltimore, US
Meredith Kilgore PhD, MSPH, Assistant Professor, UAB SOPH Health Care Organization & Policy, US
Nathan Kleinman PhD, Director of Analysis and Research, OCI, US
Maria Koltowska-Haggstrom MD, Project Manager, Pharmacia AB, Sweden
Lincy Lal PhD, PharmD, Assistant Professor, Texas Southern University - College of Pharmacy, US
Deepa Lalla, Health Economist, Amgen, Inc., US
Paul Langley PhD, US International Manager, Health Economics, 3M Pharmaceuticals, US
Anandi Law PhD, Assistant Professor in Social Administration Sci., Western University of Health Sciences, US
Shelah Leader PhD, Director, Pharmacoeconomics and Outcomes Research, Medimmune, US
Christopher Leibman PhD, Associate Director, Respiratory, AstraZeneca, US
Barbara Edelman Lewis PhD, MHA, Director, Health Economics and Outcomes Research, AstraZeneca, US
Nick Lipskiy PhD, MBA, Director of Biostatistics, Surveillance Data Inc, US
Eva Lydick PhD, Lovelace Clinic Foundation US
Larry Lynd, McMaster University, Canada
Neil MacKinnon PhD, RPh, Assistant Professor, Dalhousie University, Canada
Sunny Mahajan PhD, Director, GlaxoSmithKline, US
Vittorio Maio PharmD, Thomas Jefferson University, US
Susan Malecha, National Manager, Clinical Managers, US
William Marder PhD, Senior Vice President & General Manager, Medstat, US
Carlo Marra BSc, PharmD, FCSHP, University of British Columbia, B.C./Canada
Wallace Marsh PhD, Assistant Professor, Nova Southeastern University, US
Susan Mathias MPH, Vice President, Ovation Research Group, US
Josephine Mauskopf PhD, RTI Health Solutions, US
Doreen McBride MBA, Research Associate, Institute of Social Medicine, Epidemiology and Health Ecomonics, Germany
Joseph Menzin PhD, President, Boston Health Economics, Inc., US
Lamont Muchmore, Sr. Analyst, OCI, US
Maureen Neary PhD, Director, Specialty Care Outcomes, Hoffmann-La Roche, Inc., US
Lars Nicklasson PhD, Pharmacoeconomics Manager, Novo Nordisk Pharmaceuticals, Inc., US
Mark Nuijten PhD, MD, MBA, Director of European Business Development, MEDTAP International, The Netherlands
Tursynbek Nurmagambetov MS, PhD, Economist, CDC, US
Judith O'Brien Rn. BSPA, Caro Research, US
Robert Ohsfeldt PhD, Professor, Dept. of Health Mgmt & Policy, University of Iowa, US
MerriKay Oleen-Burkey PhD, Director, Health Outcomes Research, Teva Neuroscience, Inc., US
Mohamed Omar PhD, RPh, Outcomes Research Manager, Novartis Pharmaceuticals Corporation, US
George Papadopoulos BSc, Director, Johnson & Johnson, US
Chris Pashos PhD, Vice Pres & Executive Director of HERQuLES, Abt Associates – HERQuLES, US
John E. Paul PhD, Global Head, Business Strategy and Development, RTI Health Solutions, US
Andrew Peterson PharmD, Assistant Professor, University of the Sciences in Philadelphia, US
James Piercy BSc, MSc, Project Director, MAPI Values , UK
Andreas Pleil PhD, Director/Team Leader Worldwide Outcomes Researchomics, Pfizer Incorporated, US
Francoise Pradel PhD, Assistant Professor, University of Maryland, US
George Provenzano PhD, Senior Research Scientist, Battelle Memorial Institute, US
Eric Qiong Wu PhD, Associate, Analysis Group, US
Jeffrey Quon DC, FCCSC, MHSc, University of British Columbia, Canada
Ateequr Rahman MBA, PhD, Assistant Professor, St. John's University, US
Rukmini Rajagopalan MBA, DrPH, Senior Manager, Outcomes Research, Takeda Pharmaceuticals North America, Inc., US
Karen Rascati RPh, PhD, Professor, University of Texas, US
Aran Ratcliffe PhD, Senior Health Economist, AstraZeneca, UK
Prabashni Reddy RPh, BS, MS, PharmD, Lead Pharmacoeconomist, Abt Associates, US
Gene Reeder PhD, RPh, BS, MS, Professor, University of South Carolina, US
Margaret Rothman PhD, Executive Director, Health Economics, Johnson and Johnson Pharmaceutical Research and Development, US
Marcia FT Rupnow PhD, Assistant Director, Outcomes Research, Janssen Pharmaceutica, Inc, US
Mason W. Russell MAPE, Director, Market Economics, Biogen, Inc., US
Nishan Sengupta PhD, Assistant Director, Abbott Labs, US
Hemal Shah RPh, BS, PharmD, Director, Health Economics, Boehringer Ingelheim Pharmaceuticals, Inc., US
Fadia Tohme Shaya PhD, MPH, Assistant Research Professor, University of Maryland School of Pharmacy, US
Judith Shinogle PhD, Assistant Professor, University of South Carolina, US
Dean Smith PhD, Professor, University of Michigan, US
Dave Smith PhD, Investigator, Kaiser Permanente Center for Health Research, US
Harry Smolen MS, President, Medical Decision Modeling Inc., US
Seema Sonnad PhD, Associate Professor, Dept of Surgery, University of Pennsylvania, US
Bradley Stolshek Pharm.D., Manager – Inflammation, Amgen, Inc., US
Erin Sullivan MPH, PhD, Senior Manager, Health Economics & Outcomes Research, Boston Scientific Corporation, US
Kent Summers RPh, PhD, Research Scientist, Purdue University, US
Sheryl Szeinbach PhD, RPh, BS, MS, Professor, Ohio State University, US
Tammy Tengs ScD, Assistant Professor, University of California Irvine, US
Simu Thomas PhD, Manager, Novartis, US
George Torrance PhD, Professor Emeritus, McMaster University, VP, Innovus Research Inc., Canada
F. Randy Vogenberg PhD, RPh, Vice President & National Pracitice Leader, Aon Health System Education & Pharma Consulting, US
Samuel Wagner PhD, RPh, Senior Manager, Pfizer Inc., US
John H. Walker PhD, Assistant Professor, Brock University, Canada
Katrine Wallace MA, Manager, Health Economics & Outcomes Research, TAP Pharmaceuticals, US
Peter Wong PhD, MBA, RPh, Vice-President, Clinical Effectiveness & PI, Good Samaritan Hospital, US
Chunliu Zhan MD, PhD, Senior Service Fellow, Agency for Healthcare Research & Quality, US
Zhiyuan Zhou PhD, Sr. Scientist, Pfizer, US

***Assistant Chairperson, 9th Annual International Meeting Abstract Review Committee
 


9th Annual International Meeting Main Page

 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.